EP3264137A1 - Phantom zur dreidimensionalen dosimetrie - Google Patents

Phantom zur dreidimensionalen dosimetrie Download PDF

Info

Publication number
EP3264137A1
EP3264137A1 EP16177569.7A EP16177569A EP3264137A1 EP 3264137 A1 EP3264137 A1 EP 3264137A1 EP 16177569 A EP16177569 A EP 16177569A EP 3264137 A1 EP3264137 A1 EP 3264137A1
Authority
EP
European Patent Office
Prior art keywords
phantom
particles
matrix
dimensional
scanning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16177569.7A
Other languages
English (en)
French (fr)
Inventor
Peter Balling
Ellen Marie Høye
Michael Sadel
Peter Sandegaard Skyt
Ludvig Paul Muren
Jørgen Breede Baltzer Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aarhus Universitet
Original Assignee
Aarhus Universitet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aarhus Universitet filed Critical Aarhus Universitet
Priority to EP16177569.7A priority Critical patent/EP3264137A1/de
Publication of EP3264137A1 publication Critical patent/EP3264137A1/de
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
    • G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
    • G01T1/02—Dosimeters
    • G01T1/10—Luminescent dosimeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048—Monitoring, verifying, controlling systems and methods
    • A61N5/1075—Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/58—Testing, adjusting or calibrating thereof
    • A61B6/582—Calibration
    • A61B6/583—Calibration using calibration phantoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048—Monitoring, verifying, controlling systems and methods
    • A61N5/1075—Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus
    • A61N2005/1076—Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus using a dummy object placed in the radiation field, e.g. phantom

Definitions

  • the present invention relates to a dosimeter for measuring ionizing radiation, and more particularly to a phantom for three-dimensional dosimetry via optically stimulated luminescence and corresponding method for preparation and use.
  • Radiotherapy is a treatment involving the use of radiation, in particular ionizing radiation. It may for example be used to treat cancer, where high-energy radiation used during radiotherapy permanently damages the DNA of cancer cells, causing them to die.
  • an improved three-dimensional dosimeter or phantom would be advantageous, and in particular it would be advantageous with a three-dimensional dosimeter or phantom which is re-usable, enables simplified readout, is less sensitive to oxidation, is stable, has dose-rate independent response and/or has physical properties enabling avoidance of artefacts.
  • a phantom such as a phantom suitable for three-dimensional dosimetry, comprising:
  • the invention is particularly, but not exclusively, advantageous for providing a phantom (i.e., a model of a part of the human body), which can be subjected to radiation and which phantom can subsequently be subjected to examination revealing the dose distribution.
  • a phantom i.e., a model of a part of the human body
  • This may for example be relevant for validating (before actually subjecting a patient to the radiation) that a dose distribution of radiation does in fact correspond to the area requiring treatment, while leaving healthy tissue as unaffected as possible.
  • An advantage of said phantom may be, that it enables benefitting from good dosimetric properties of typically relatively expensive optically stimulated luminescence (OSL) material in a relatively inexpensive way, since the phantom volume is furthermore occupied by potentially relatively inexpensive matrix material.
  • OSL optically stimulated luminescence
  • the present invention may enable the well established, good dosimetric properties of OSL materials being combined with a potentially relatively inexpensive matrix of good optical properties (and optionally good mechanical properties with respect to the mechanical properties of the material of the particles), which matrix can be used to suspend particles of the preferred OSL material in a phantom of a desired 3D shape, which phantom has dimensions and optical properties, which makes it suitable for use as a three-dimensional dosimeter.
  • Another advantage may be, that mechanical properties of said phantom with OSL particles may be at least partially decoupled from the mechanical properties of the material of the OSL particles, since mechanical properties can be controlled via the matrix.
  • Another advantage may be that the phantom is re-usable since electron-hole pairs in the OSL material can be repeatedly excited by ionizing radiation and recombined by optical stimulation (i.e., OSL dosimeters can be reset by, e.g., high temperature and/or an optical bleaching procedure).
  • optical stimulation i.e., OSL dosimeters can be reset by, e.g., high temperature and/or an optical bleaching procedure.
  • Another advantage may be that readout may be kept relatively simple, since the phantom may be scanned via optical stimulation and/or since the luminescence results in photons from the irradiated voxels, which may be directly imaged.
  • Another possible advantage in terms of simplifying the readout is that irradiation does not change the refractive index. Another possible advantage may be relatively high stability and little or no sensitivity towards oxidation, which may potentially simplify storage and use. Another possible advantage may be dose-rate independent response, which may simplify data analysis. Another possible advantage is that readout may be carried out subsequent to irradiation, such as seconds, minutes, hours or days subsequent to irradiation, which may enable readout elsewhere than at the site of irradiation, which may in turn be beneficial for enabling irradiation, e.g., in a strong magnetic field where electronic devices are not applicable, and then subsequent readout without the strong magnetic field with electronic devices. Other possible advantages include good tissue equivalence and/or no dependence on external factors (such as humidity or temperature).
  • 'phantom' is to be understood a mechanical model, such as a mechanical model of a human or animal body part, such as an anthropomorphic model, which phantom enables measuring a dose of irradiation which the phantom may be subjected to. More particularly, the phantom may change properties and/or emit radiation upon irradiation and optionally stimulation, which change in properties and/or emitted radiation may be indicative of the dose of irradiation. Said phantom may be non-biological, such as not comprising living or dead tissue. Phantom may be employed interchangeably with "three-dimensional dosimeter".
  • 'matrix' is to be understood a material in which something is enclosed or embedded.
  • the matrix of the phantom may be understood to be solid, homogeneous, monolithic and/or polymeric.
  • particles' may be understood solid structures which have relatively small volume and dimensions with respect to the volume and dimensions of the matrix material.
  • the particles may comprise or consist of crystalline material.
  • the particles may have dimensions, such as dimensions in each and all 3 geometrical directions, within one micrometer to hundreds of micrometers, such as within 50-200 micrometer, such as within 100-200 micrometer.
  • 'embedded (in said matrix)' may be understood to enclose closely, such as to make the embedded structure(s) an integral part of the embedding structure, such as the matrix and the embedded particles forming an integral structure.
  • 'enclose closely' may be understood that there is little or substantially no, such as no, air (or other gas-filled) gap between the embedding (matrix) and embedded (particles) material, such as any gap is equal to or smaller than 1 times, such as 0.5 times, such as 0.25 times, such as 0.1 times, such as 0.01 times, the smallest wavelength of the optically stimulating wavelength and the wavelength of the photons emitted as optically stimulated luminescence.
  • OSL optically stimulated luminescence'
  • OSL material is radiation excitable (such as electrons in the particles may be brought into trapped states via ionizing radiation) and capable of emitting optically stimulated luminescence (such as may be brought to luminesce via stimulation with electromagnetic radiation, such as incident electromagnetic radiation may trigger recombination of electrons from the trapped states releasing energy as stimulated radiative luminescence).
  • Optically stimulated luminescence employs dielectric crystalline materials with long-lived defect states (such as point defects in the crystal lattice, which are usually intentionally introduced by doping) in their band gaps, which can be populated by ionizing radiation.
  • defect states such as point defects in the crystal lattice, which are usually intentionally introduced by doping
  • the population of these trapped states may be read out by irradiating the sample with a moderately intense light source of appropriate wavelength to promote the trapped electrons to the conduction band and detecting the luminescence at shorter wavelength from, e.g., inter-band (electron-hole) recombination.
  • the whole process is typically recorded by a photomultiplier tube (PMT) inside an OSL reader, which is equipped with light sources of wavelengths specified according to the OSL material, such as OSL particles, used.
  • PMT photomultiplier tube
  • OSL reader which is equipped with light sources of wavelengths specified according to the OSL material, such as OSL particles, used.
  • the time-dependent luminescent signal and optionally the so-called OSL decay-curve
  • Practical use of the OSL method may be facilitated by efficient light sources in the form of LEDs and/or lasers.
  • OSL materials Materials which enable OSL may be interchangeably referred to as OSL materials, OSL active materials and/or optically stimulable luminescent materials.
  • the particles of the present invention are understood to comprise, such as consist of, an OSL material.
  • a size of the phantom along each and all of the three geometrical dimensions' may be understood that for at least one choice of Cartesian coordinate system, the largest length of the phantom along each of the three axes is at least a given size.
  • the phantom at least fills a volume corresponding to a solid cube with a side length corresponding to the given size.
  • An advantage of having a size of at least 10 x 10 x 10 mm 3 may be that this matches a length scale, which is relevant for humans, and which may be resolved in three-dimensions, e.g., for voxels being 1 x 1 x 1 mm 3 .
  • An advantage of having a larger size may be that it enables matching length scales or larger structures or regions within a human.
  • an attenuation coefficient of the phantom is equal to or less than 10 cm -1 , such as equal to or less than 6.9 cm -1 , such as equal to or less than 5.0 cm -1 , such as equal to or less than 2.0 cm -1 , such as equal to or less than 1.4 cm -1 , such as equal to or less than 1.0 cm -1 , such as equal to or less than 0.9 cm -1 , at a wavelength, where optical stimulation of the particles can be carried out and/or at a wavelength where stimulated luminescence takes place.
  • An advantage of this may be that it enables getting photons in to and/or out of an interior voxel, such as a voxel lying at least 1 cm from an outer interface of the phantom, while still carrying information regarding their initial direction.
  • the attenuation coefficient may be obtained as is common in the art, such as via measurement in a standard spectrophotometer, which measures the absorption though, e.g., a 1 cm cuvette.
  • a phantom wherein said wavelength is within 200-1200 nm, such as within 200-1100 nm, such as within 400-1100 nm, such as within 400-1000 nm, such as within 400-800 nm.
  • An advantage of this may be that the wavelength matches a wavelength wherein at least some relevant matrix materials (such as polymers) have good optical properties.
  • An advantage of the 400-800 nm region may be that it matches the optically visible region, which has traditionally been employed in medical settings.
  • a phantom wherein the phantom is arranged so as to enable that upon 1 Gy irradiation of the phantom with ionizing radiation, such as wherein said ionizing radiation is beta radiation, then at least 4000 photons can be emitted, such as emitted within 1 second upon stimulation with a Risoe TL/OSL DA-20 OSL reader (such as using an intensity of ⁇ 80 mW/cm 2 at the sample), from a voxel of 1 x 1 x 1 mm 3 via stimulated luminescence and traverse at least 1 cm of the phantom before reaching a detector.
  • ionizing radiation such as wherein said ionizing radiation is beta radiation
  • An advantage of this may be that a sufficient number of photons may then be received at a detector for the purpose of having sufficiently good statistics, such as achieving a statistical spread of approximately 2 %.
  • a phantom wherein the phantom is arranged so as to enable that upon 1 Gy irradiation of the phantom with ionizing radiation, such as wherein said ionizing radiation is beta radiation, then at least 1000 photons, such as at least 2000 photons, such as at least 3000 photons can be emitted, such as emitted within 1 second upon stimulation with a Risoe TL/OSL DA-20 OSL reader (such as using an intensity of ⁇ 80 mW/cm 2 at the sample), from a voxel of 1 x 1 x 1 mm 3 via stimulated luminescence and traverse at least 1 cm of the phantom before reaching a detector.
  • ionizing radiation such as wherein said ionizing radiation is beta radiation
  • An advantage of this may be that a sufficient number of photons may then be received at a detector for the purpose of having sufficiently good statistics, such as achieving a statistical spread of approximately 3 % (which is typically required for clinical purposes) corresponding to 1000 particles.
  • the phantom is arranged' may be understood an interplay between optical properties of matrix material and optical properties of the particles (including their OSL properties) and the optical properties of each of the matrix and the particles, such as having chosen matrix and particles which enable yielding a sufficient OSL response and which simultaneously enables optical transmission through the matrix as such and the composition comprising matrix and particles.
  • 1 cm may be a typical length scale of human anatomical structures and 1 mm 3 may be typical size of a voxel within the field of 3D dosimetry.
  • a density of said particles in said matrix is within 0.00001 to 0.0010 g/mm 3 , such as within 0.00003 to 0.0001 g/mm 3 , such as such as within 0.00003 to 0.00006 g/mm 3 or such as such as within 0.00004 to 0.00009 g/mm 3 .
  • An advantage of this may be that it enables providing a good OSL signal (such as sufficient number of photons emitted from the particles) while at the same time providing good optical properties (i.e., low attenuation coefficient), which in turn enables that a good number of optically stimulated luminescence photons can reach a detector, even if originating from voxels within the phantom.
  • a phantom wherein the material of the phantom has a Young's Modulus of 2 megapascal or less, such as within ]0;2] MPa, such as within [2; 1000] kPa, such as within [2; 600] kPa, such as within [2; 35] kPa and/or within [30; 600] kPa.
  • An advantage of this may be that it enables mimicking the mechanical properties of body parts, such as human body parts, which have Young's modules ranging between 0.001 and several megapascal.
  • Another possible advantage may be that it enables that the phantom may be deformed during irradiation, such as giving possibilities to simulate organ deformation during irradiation in realistic geometries.
  • a phantom wherein said matrix comprises silicone, such as a silicone elastomer, such as Sylgard® 184 (Dow Corning), and/or wherein said particles comprise lithium fluoride (LiF) doped with magnesium, copper and phosphorus (LiF:Mg,Cu,P), such as wherein the lithium fluoride (LiF) doped with magnesium, copper and phosphorus is enriched (with respect to natural Li) with lithium-6 isotope, with lithium-7 isotope or an other neutron converter material.
  • An advantage of enriching or having another neutron converter material may be that it increases the cross-section with respect to neutrons, hence enables detection of neutron radiation. Neutron converters are described by E.G.
  • LiF:Mg,Cu,P may be referred to as "MCP".
  • the matrix may be given by a polymeric material such as, polydimethylsiloxane silicones (PDMS), such as the Silicone Elastomer Kit SYLGARD® 184 consisting of preweighed monomer (base) and curing agent.
  • PDMS polydimethylsiloxane silicones
  • Silicone may be understood as is common in the art, more particularly as an inorganic silicon-oxygen backbone chain (...-Si-O-Si-O-Si-O-...) with organic side groups attached to the silicon atoms. Silicones have in general the chemical formula [R 2 SiO] n , where R is an organic group, such as methyl, ethyl, or phenyl.
  • a phantom further comprising a radiochromic dye, such as leucomalachite green, embedded within said matrix.
  • a radiochromic dye such as leucomalachite green
  • a ratio between the refractive indices of the matrix material and the particles at a wavelength, where optical stimulation of the particles can be carried out and/or at a wavelength where stimulated luminescence takes place is equal to or less than 1.05, such as equal to or less than 1.04, such as equal to or less than 1.03, such as equal to or less than 1.02, such as equal to or less than 1.015, such as equal to or less than 1.01.
  • An advantage of this may be that the relatively low ratio ensures a relatively low amount of refraction and scattering at the boundaries between the matrix material and the particles. For the purposes of the ratio calculation, it is to be understood that it is always equal to or larger than unity.
  • the optical properties of the phantom may depend not only on the (isolated) optical properties of the matrix as such and/or the optical properties of the matrix as such, but also on the relation between the optical properties of the matrix and the particles, such as the ratio of their refractive indices, since increasing this ratio may decrease the attenuation coefficient of the phantom, regardless of the respective attenuation coefficients of the matrix and the particles.
  • a method for preparing a phantom according to the first aspect comprising, such as comprising the following steps in the sequence in which they are listed:
  • a phantom according to the first aspect and/or as prepared according to the second aspect for any one of:
  • 'Three-dimensional (3D) radiation dosimetry' is understood as is common in the art, more particularly as the process of experimental (as opposed to theoretical calculations or numerical simulations) determination of the spatial distribution of the absorbed dose of ionising radiation, more particularly exposure of a three-dimensional dosimeter, such as phantom, to the ionizing radiation and subsequently estimating three-dimensional (3D) dose distribution by measuring changes in the dosimeter, which correlates with the amount of ionizing radiation.
  • 'Linear energy transfer' (LET) is understood as is common in the art, such as is described by Granville et al. in the reference Physics in Medicine and Biology, Vol. 61, p. 1765-1779 (2016 ) which is hereby incorporated by reference in entirety.
  • 'Ionizing radiation' is understood as is common in the art, more particularly to include energetic subatomic particles, ions or atoms moving at high speeds (such as greater than 1% of the speed of light) and/or electromagnetic waves (such as within the high-energy end of the electromagnetic spectrum).
  • the 3D dose distribution can be read out using standard optical CT scanners.
  • the read out can be based on an appropriately designed combination of an illuminating light source and an optical-detection setup for the luminescent light, which together determines the 3D distribution.
  • the illuminating light source is a laser, which illuminates a specific part of the dosimeter and the detection is based on an appropriate optical filter in combination with a photo multiplier tube (PMT), an image-intensified camera (ICCD) or an electron-multiplication camera (EMCCD).
  • PMT photo multiplier tube
  • ICCD image-intensified camera
  • ECCD electron-multiplication camera
  • Stimulation modes being 'continuous, pulsed, linear' is understood as is common in the art and more particularly as continuous wave OSL, or CW-OSL, pulsed-OSL (POSL), linear modulation OSL, or LM-OSL as described by M.S. Akselrod et al. in Radiation Measurements 41 (2007) S78 - S99 which is hereby incorporated by reference in entirety.
  • both the stimulating radiation and the stimulated luminescence travels through other voxels (between internal voxels and, respectively, a source of stimulating radiation and a detector) for which other voxels the dose also has to be estimated.
  • This may be advantageous for dispensing with a need for physically disassembling, such as physically slicing, the phantom.
  • irradiating the phantom with electromagnetic radiation, such as so as to optically stimulate luminescence may be partially or fully replaced with heating the phantom, such as so as to thermally stimulate luminescence.
  • mapping' may be understood obtaining information regarding the spatial origin within the phantom of the stimulated luminescence. Such mapping may thus be employed to determine spatially, in three dimensions, where (such as from which voxels), the stimulated luminescence originates.
  • the information regarding the spatial origin may be obtained, e.g., by scanning the phantom with stimulating electromagnetic radiation and/or using imaging optics which not only detects a photon, but also obtain information regarding its origin, such as from which voxel if was emitted.
  • mapping' By 'estimating three-dimensional dose distribution based on said mapping' may be understood that the information gained from the mapping may be used to obtain information on dose distribution, since the amount of stimulated luminescence may correlated with the dose of ionizing radiation.
  • said irradiating comprises:
  • the scanning comprises:
  • the illuminating laser can illuminate a specific plane of a thickness below 1 mm and a camera can image the luminescence light from this plane (from a position outside of the plane).
  • a camera can image the luminescence light from this plane (from a position outside of the plane).
  • the two-dimensional dose distribution of said plane can be measured, and by shifting said plane relative to the dosimeter, the 3D dose distribution can be obtained by building up stacks of 2D distributions.
  • the first, second and third aspect of the present invention may each be combined with any of the other aspects.
  • Dosimeters of a shape appropriate for a commercial OSL reader have been prepared, more particularly dosimeters with a diameter of 7-8 mm and thickness below 1 mm cast directly on a small metal disk.
  • the dosimeter samples were made in standard OSL aluminium trays carrying a volume corresponding to a circular disc of 8 mm diameter times ⁇ 1 mm thickness.
  • the particles comprising OSL material are given by particles of lithium fluoride (LiF) doped with magnesium, copper and phosphorus (LiF:Mg,Cu,P), also known as "MCP".
  • the matrix is given by a silicone elastomer (more particularly Polydimethylsiloxane elastomer) and curing agent, Sylgard® 184 Silicone Elastomer Kit (Dow Corning).
  • the curing agent and the silicone elastomer were used in a 1:10 weight ratio. Silicone was first mixed with the curing agent and next with the LiF:Mg,Cu,P luminescence powder. Air bubbles were removed from the dosimeter by use of a vacuum desiccator. The samples were mixed before being poured into the disks.
  • the disks were standard used in commercial OSL readers metal trays with a diameter between 7-8 mm and thickness 1 mm. The dosimeters were placed for 30 minutes in an oven kept at 60 degrees centigrade to accelerate the curing process.
  • Figure 1 shows OSL decay-curves showing the number of counts in 0.4 s time bins from different samples with MCP and/or silicone obtained by irradiating with a Beta source with a dose of 1 Gy.
  • the OSL was stimulated with blue light at a room temperature using a commercial OSL reader with UV filter and a PMT.
  • Fig. 1 the OSL decay curves of different samples, obtained after irradiations with Beta radiation are compared.
  • the total beta dose was at the level of 1 Gy in all cases.
  • the OSL read outs were performed using a Risoe TL/OSL DA-20.
  • the samples were stimulated with blue light emitting diodes (LEDs), with emission centered at 470 nm and an intensity of ⁇ 80 mW/cm 2 at the sample.
  • LEDs blue light emitting diodes
  • the stimulation wavelength range for MCP powder is 450-550 nm and the luminescence wavelengths are 250-425 nm (as taken from the data for the Risoe reader employing a UV-340 optical filter with main transmission between 250-400 nm, and blue light emitting diodes 470 nm for stimulation, as mentioned above).
  • the period of stimulation was 100 s.
  • the dosimeter samples were made in standard OSL aluminium trays carrying a volume corresponding to a circular disc of 8 mm diameter times ⁇ 1 mm thickness.
  • the measurement shows that the OSL signal from MCP embedded in silicone (shown in the upper, dashed curve 102) was significantly higher than that of MCP powder (shown in the middle, full drawn curve 104).
  • the lower, dotted curve 106 shows the signal for an empty probe.
  • the two samples used approximately the same amount of dosimeter material (0.045 g for pure MCP powder; 0.068 g for MCP in silicone).
  • the higher response may be due to an improved emission of the OSL light from the embedded (optically contacted) particles compared to the translucent powder.
  • the silicone matrix in itself does not add to the OSL signal.
  • a sample according to EXAMPLE 1 with combined silicone and MCP powder gives ⁇ 4 ⁇ 10 7 counts in the first second from a standard-size test sample (MCP powder + silicone) after a dose of 1 Gy (this can be seen in the FIG. 1 ).
  • This signal originates from an area of pi ⁇ (4 mm) 2 , i.e. 50 mm 2 .
  • the thickness can be estimated as ⁇ 1.3 mm - comparable to an appropriate thickness of a light sheet in 3D read out.
  • the luminescence light may possibly be reflected from the metal disk behind the dosimeter material (giving approximately a factor of two higher collection efficiency).
  • We thus estimate that the expected signal from a 1 mm thick slab of a 3D dosimeter will be down by a factor of two. This means that - for a dose of 1 Gy - we should expect ⁇ 4-10 7 /50/2 400,000 counts from each 1 mm 3 voxels.
  • the solid angle in the commercial OSL reader is quite high, covering maybe light emitted within ⁇ 45° from the sample (i.e. an N.A. of ⁇ 0.7 equivalent to an f number (f#) of f/0.7). It may be difficult to match this collection efficiency with an imaging setup, although fairly-large-lensed objectives are available, e.g. telecentric lenses with f/2.8. We may thus expect to lose some light (e.g. a factor of 4) compared to the PMT setup.
  • the detection efficiency in a state-of-the-art EMCCD single-photon camera
  • the detection efficiency in a state-of-the-art EMCCD is similar to (or even higher than) that of a PMT, so we should still have a large dynamic range covering the clinically relevant doses.
  • the dosimeter material is applicable for real dosimetric applications.
  • the response of MCP to beta radiation is known to be lower than to gamma radiation. This issue is commonly known as the luminescence efficiency. For weakly ionizing radiation (e.g. photons), the luminescence efficiency must be assumed as equal unity. For strongly ionizing radiation (particles), the efficiency usually decreases.
  • the response (signal) from the detector will be lower for beta particles than for photons. This effect is especially observable for heavy charged particles like protons. Taking this into account, we should expect even higher signal for gamma radiation comparing to the beta data on the figure 1 .
  • the signal levels will be similar to those for beta radiation. Signal levels above were calculated over one second although more OSL light could be acquired if the full OSL decay curve is measured. Note that the signal per unit time depends on the intensity of the exciting light source.
  • Figure 2 shows a phantom 210 which has been prepared in a 1 cm x 1 cm x 5 cm cuvette 200.
  • the material choices are MCP microcrystals (as the OSL particles) embedded in a matrix given as silicone elastomer and curing agent, Sylgard® 184 Silicone Elastomer Kit (Dow Corning).
  • the width 212 of the phantom is thus 1 cm and the height 214 is approximately 3.5 cm.
  • the curing agent and the silicone elastomer were used in a 1:10 weight ratio. Silicone was first mixed with the curing agent and next with the LiF:Mg,Cu,P luminescence powder. Air bubbles were removed from the dosimeter by use of a vacuum desiccator. The samples were mixed before being poured into the appropriate cuvettes.
  • the cuvettes were standard PMMA cuvettes 1 cm x 1xm x 5 cm. They were subsequently placed into the oven to accelerate curing process as in Example 1.
  • the phantom is transparent to the naked eye. This transparency may at least partially be caused by index matching of the refractive indices of the matrix and the particles.
  • Figure 3 shows the refractive index of the matrix 216 (in the form of the refractive index of the silicone as employed in EXAMPLES 1-2) and LiF 218 (i.e., lithium fluoride, which forms the base material of MCP, which is employed for the particles in EXAMPLES 1-2).
  • LiF 218 i.e., lithium fluoride, which forms the base material of MCP, which is employed for the particles in EXAMPLES 1-2.
  • Figure 4 shows the absorbance of (in the lower curve) the silicone employed in EXAMPLES 1-2 (without particles), (in the middle curve) the silicone with the particles as provided in EXAMPLE 2 where the silicone attenuation has been subtracted, and (in the top curve) the silicone with the particles as provided in EXAMPLE 2.
  • Figure 5 shows absorbance of a sample with silicone and particles.
  • the size of the MCP particles in EXAMPLES 1-2 is from 100 - 200 micrometer. Therefore it may be presumed to have a maximum of around 100 single grains in a 1mm 3 voxel.
  • the mass concentration of MCP ⁇ 0.00003 g/mm 3 indicates a few particles per 1 mm 3 voxel.
  • Figure 6 shows a microscope image of a cross-sectional plane within the cuvette as depicted in figure 2 , where particles 220 and matrix 222 can be seen.
  • the image width 224 is 1.1 mm and the image height 226 is 0.9 mm. From such images taken at different cross-sections, it can be derived, that the number of particles is 10-20 per mm 3 in the middle of the cuvette.
  • Figure 7 shows a schematic of a setup for carrying out a method, more particularly the method wherein scanning comprises:
  • the figure shows a side view in sub-figure (a) and a top view in sub-figure (b).
  • the figures depict a laser beam 730 forming a sheet of light, which beam scanning (as indicated by arrow 732) a phantom 734.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Molecular Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Radiation-Therapy Devices (AREA)
EP16177569.7A 2016-07-01 2016-07-01 Phantom zur dreidimensionalen dosimetrie Withdrawn EP3264137A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP16177569.7A EP3264137A1 (de) 2016-07-01 2016-07-01 Phantom zur dreidimensionalen dosimetrie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16177569.7A EP3264137A1 (de) 2016-07-01 2016-07-01 Phantom zur dreidimensionalen dosimetrie

Publications (1)

Publication Number Publication Date
EP3264137A1 true EP3264137A1 (de) 2018-01-03

Family

ID=56292615

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16177569.7A Withdrawn EP3264137A1 (de) 2016-07-01 2016-07-01 Phantom zur dreidimensionalen dosimetrie

Country Status (1)

Country Link
EP (1) EP3264137A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108169783A (zh) * 2018-02-26 2018-06-15 苏州大学 一种辐射空间剂量分布的实时测量装置及测量方法
EP4066889A1 (de) 2021-03-30 2022-10-05 Agfa Nv 3d-druckmaterial für dosismessphantome

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140028A (en) * 1965-03-09 1969-01-15 Isotopes Inc Improvements in or relating to thermoluminescent radiation dosimeters
US6249004B1 (en) * 1998-10-07 2001-06-19 Sunna Systems Corp. Inorganic crystal based composite material high dose dosimeter and method of using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140028A (en) * 1965-03-09 1969-01-15 Isotopes Inc Improvements in or relating to thermoluminescent radiation dosimeters
US6249004B1 (en) * 1998-10-07 2001-06-19 Sunna Systems Corp. Inorganic crystal based composite material high dose dosimeter and method of using same

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BENGT E BJARNGARD ET AL: "LITHIUM FLUORIDE-TEFLON THERMOLUMINESCENCE DOSIMETERS", LUMINESCENCE DOSIMETRY. PROCEEDINGS OF INTERNATIONAL CONFERENCE ON LUMINESCENCE DOSIMETRY, STANFORD UNIVERSITY, STANFORD, CALIFORNIA, JUNE 21-23, 1965, WASHINGTON, U.S.<PUBATTR/>,, 21 June 1965 (1965-06-21), pages 308 - 316, XP001262376 *
E.G. YUKIHARAA ET AL., RADIATION MEASUREMENTS, vol. 43, 2008, pages 309 - 314
GRANVILLE ET AL., PHYSICS IN MEDICINE AND BIOLOGY, vol. 61, 2016, pages 1765 - 1779
M.S. AKSELROD ET AL., RADIATION MEASUREMENTS, vol. 41, 2007, pages S78 - S99
ROLF B. SAAGER ET AL: "Multilayer silicone phantoms for the evaluation of quantitative optical techniques in skin imaging", OPTICAL SENSING II, vol. 7567, 11 February 2010 (2010-02-11), 1000 20th St. Bellingham WA 98225-6705 USA, pages 756706, XP055329827, ISSN: 0277-786X, ISBN: 978-1-62841-971-9, DOI: 10.1117/12.842249 *
RUAN CHUN ET AL: "Determination of multislice computed tomography dose index (CTDI) using optically stimulated luminescence technology", MEDICAL PHYSICS, AIP, MELVILLE, NY, US, vol. 37, no. 7, 15 June 2010 (2010-06-15), pages 3560 - 3568, XP012144828, ISSN: 0094-2405, DOI: 10.1118/1.3455285 *
RUIQI LONG ET AL: "Design of an Optical System for Interrogation of Implanted Luminescent Sensors and Verification with Silicone Skin Phantoms", IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, IEEE SERVICE CENTER, PISCATAWAY, NJ, USA, vol. 59, no. 9, 1 September 2012 (2012-09-01), pages 2459 - 2465, XP011490182, ISSN: 0018-9294, DOI: 10.1109/TBME.2012.2203306 *
THOMPSON, HIRST, ANDREWS: "Is there a difference between laser speckle and laser Doppler in depthsensitivity?", SPIE, PO BOX 10 BELLINGHAM WA 98227-0010, USA, vol. 7897, 2011, XP040554055 *
VASILIEV, GAMALIY, ZAYTSEV: "CT vs. volumescope: image quality and dose comparison", SPIE, PO BOX 10 BELLINGHAM WA 98227-0010 USA, vol. 5943, 2005, XP040215220 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108169783A (zh) * 2018-02-26 2018-06-15 苏州大学 一种辐射空间剂量分布的实时测量装置及测量方法
EP4066889A1 (de) 2021-03-30 2022-10-05 Agfa Nv 3d-druckmaterial für dosismessphantome

Similar Documents

Publication Publication Date Title
Olko Advantages and disadvantages of luminescence dosimetry
Moses et al. Cerium fluoride, a new fast, heavy scintillator
Kelly et al. Optical CT reconstruction of 3D dose distributions using the ferrous–benzoic–xylenol (FBX) gel dosimeter
Babic et al. Radiochromic leuco dye micelle hydrogels: II. Low diffusion rate leuco crystal violet gel
Beaulieu et al. Current status of scintillation dosimetry for megavoltage beams
Stevens et al. High-resolution dosimetry using radiochromic film and a document scanner
C. Polf et al. A real-time, fibre optic dosimetry system using Al2O3 fibres
Beddar et al. Plastic scintillation dosimetry: optimization of light collection efficiency
Roncali et al. Modelling the transport of optical photons in scintillation detectors for diagnostic and radiotherapy imaging
Yukihara et al. An optically stimulated luminescence system to measure dose profiles in x-ray computed tomography
Nascimento et al. Medical dosimetry using a RL/OSL prototype
Williams et al. Fiber-optic-coupled RbMgF3: Eu2+ for remote radiation dosimetry
EP3264137A1 (de) Phantom zur dreidimensionalen dosimetrie
Nillius et al. Light output measurements and computational models of microcolumnar CsI scintillators for x‐ray imaging
Sądel et al. Two-dimensional radiation dosimetry based on LiMgPO4 powder embedded into silicone elastomer matrix
Yukihara et al. Applications of optically stimulated luminescence in medical dosimetry
Geber-Bergstrand et al. Retrospective dosimetry using OSL of tooth enamel and dental repair materials irradiated under wet and dry conditions
Perks et al. Medical dosimetry using Optically Stimulated Luminescence dots and microStar readers
Gasparian et al. Using the optically stimulated luminescence technique for one-and two-dimensional dose mapping: a brief review
Yokoyama et al. Evaluation of a therapeutic carbon beam using a G2000 glass scintillator
Stabilini Development and Modelling Innovative Techniques for Neutron Dosimetry
Kim et al. Flexible optically stimulated luminescence band for 1D in vivo radiation dosimetry
Osunkwor Commissioning of an optically stimulated luminescence dosimetry (OSLD) system for in vivo dosimetry
Rusiecka et al. Investigation of the Properties of the Heavy Scintillating Fibers for Their Potential Use in Hadron Therapy Monitoring
WO2000079302A1 (en) Three-dimensional liquid scintillation dosimetry system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180704